Health Care & Life Sciences » Biotechnology | ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own ACADIA Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Fidelity Growth Company Fund
6,853,767
5.48%
-37,188
0.2%
07/31/2018
First Trust NYSE Arca Biotechnology Index Fund
4,397,039
3.52%
0
2.7%
09/05/2018
SPDR S&P Biotech ETF
4,169,422
3.34%
10,728
1.01%
09/06/2018
Fidelity Select Biotechnology Portfolio
2,882,880
2.31%
0
0.45%
07/31/2018
Vanguard Small Cap Index Fund
2,513,868
2%
36,316
0.04%
07/31/2018
Vanguard Total Stock Market Index Fund
2,504,889
2%
2,576
0.01%
07/31/2018
Janus Enterprise Fund
2,499,401
2%
0
0.19%
06/30/2018
Oppenheimer Global Fund
2,296,479
1.84%
0
0.28%
03/31/2018
iShares Russell 2000 ETF
2,059,832
1.65%
-1,101
0.06%
09/06/2018
Fidelity Series Growth Company Fund
1,994,274
1.6%
0
0.21%
07/31/2018

About ACADIA Pharmaceuticals

View Profile
Address
3611 Valley Centre Drive
San Diego California 92130
United States
Employees -
Website http://www.acadia-pharm.com
Updated 07/08/2019
ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. It operates through development and commercialization of innovative medicines segment. The company was founded by Mark R.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.